Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
£438 million investment for UCL gene therapy spinouts
UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, has raised $225 million (£173 million) through its initial public offering. The funding success adds to an unprecedented summer that saw UCL spinout companies raise £265 million of investment which could transform patient outcomes.
Novel method of analysis of stroke data
UCLB Marks 25 Years of Innovation
As this year marks our 25th anniversary, it provides the perfect time to look back on some of the remarkable achievements leading up to this point.
SnakeGrid
SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.
Latest news and highlights
Bringing innovation to life
